{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:31Z","timestamp":1789039771783,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":23,"publisher":"Springer US","isbn-type":[{"value":"9781071626504","type":"print"},{"value":"9781071626511","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2651-1_2","type":"book-chapter","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:08:04Z","timestamp":1670526484000},"page":"15-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Etiology of Retinitis Pigmentosa"],"prefix":"10.1007","author":[{"given":"Mark P.","family":"Breazzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeher R.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce W. S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2_CR1","unstructured":"(2014) Facts about retinitis pigmentosa. National Eye Institute"},{"key":"2_CR2","unstructured":"(2017) Background on Biallelic RPE65 mutation-associated retinal dystrophy. Spark Therapeutics Briefing Document: 35\u201340"},{"key":"2_CR3","unstructured":"(2017) Figure 13: The role of RPE65 in the visual cycle. Spark Therapeutics Briefing Document: 36"},{"key":"2_CR4","doi-asserted-by":"crossref","unstructured":"Hamel C (2006) Retinitis Pigmentosa. Orphanet J Rare Dis","DOI":"10.1186\/1750-1172-1-40"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT et al (2006) Retinitis pigmentosa. Lancet 368:1795\u20131809","journal-title":"Lancet"},{"key":"2_CR6","unstructured":"Retinitis Pigmentosa; RP #268000. OMIM Database"},{"key":"2_CR7","unstructured":"Gene cards: human gene database. Weizmann Institute of Science"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ng1097-194","volume":"17","author":"SM Gu","year":"1997","unstructured":"Gu SM et al (1997) Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet 17:194\u2013197","journal-title":"Nat Genet"},{"key":"2_CR9","doi-asserted-by":"crossref","unstructured":"Zhao et al. (1995) Letter. Ophthalmology Genetics: 75\u201376","DOI":"10.3109\/13816819509056916"},{"key":"2_CR10","doi-asserted-by":"crossref","unstructured":"Mansergh FC et al (1999) Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene. Am J Hum Genet:971\u2013985","DOI":"10.1086\/302344"},{"key":"2_CR11","unstructured":"(2017) Usher syndrome. Genetics Home Reference, NIH"},{"key":"2_CR12","unstructured":"(2013) Bardet-Biedel syndrome. Genetics Home Reference, NIH"},{"key":"2_CR13","unstructured":"(2013) Alport syndrome. Genetics Home Reference, NIH"},{"key":"2_CR14","unstructured":"(2011) Kearns Sayre syndrome. Genetics Home Reference, NIH"},{"key":"2_CR15","unstructured":"(2018) Abetalipoproteinemia. Genetics Home Reference, NIH"},{"key":"2_CR16","unstructured":"(2015) McLeod syndrome. Genetics Home Reference, NIH"},{"key":"2_CR17","unstructured":"(2016) Refsum disease. Genetics Home Reference, NIH"},{"key":"2_CR18","unstructured":"(2018) Laurence-Moon syndrome. National Organization for Rare Disorders"},{"key":"2_CR19","unstructured":"(2016) Cockayne syndrome. Genetics Home Reference, NIH"},{"key":"2_CR20","unstructured":"(2014) Alstrom syndrome. Genetics Home Reference, NIH"},{"key":"2_CR21","unstructured":"(2017). Leber congenital amaurosis. National Organization of Rare Diseases"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/bjo.77.2.120","volume":"77","author":"A Karma","year":"1993","unstructured":"Karma A et al (1993) Secondary retinitis pigmentosa and cerebral demyelination in Lyme borreliosis. Br J Ophthalmol 77:120\u2013122","journal-title":"Br J Ophthalmol"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2169\/internalmedicine.33.644","volume":"33","author":"J Masugi","year":"1994","unstructured":"Masugi J et al (1994) Pigmentary retinopathy with nephrotic syndrome, Menetrier\u2019s disease, and diabetes mellitus. Intern Med 33:644\u2013648","journal-title":"Intern Med"}],"container-title":["Methods in Molecular Biology","Retinitis Pigmentosa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2651-1_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T03:58:10Z","timestamp":1674273490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2651-1_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"ISBN":["9781071626504","9781071626511"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2651-1_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"9 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Stephen H. Tsang receives financial support from Abeona Therapeutics, Inc and Emendo. He is also the founder of Rejuvitas and is on the scientific and clinical advisory board for Nanoscope Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}